(Q38772860)

6 September 2017

IgG4-related nephropathy (English)

1 reference

6 September 2017

Giacomo Quattrocchio

1

1 reference

PubMed ID

26972314

6 September 2017

Dario Roccatello

series ordinal

2

1 reference

6 September 2017

14 March 2016

1 reference

6 September 2017

Journal of Nephrology

1 reference

6 September 2017

29

1 reference

6 September 2017

4

1 reference

6 September 2017

487-493

1 reference

https://scigraph.springernature.com/pub.10.1007/s40620-016-0279-4

6 September 2017

0 references

cites work

The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

21 January 2018

IgG4-related disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

IgG4-related kidney disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Consensus statement on the pathology of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

IgG4-related disease and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

The clinical spectrum of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Pathogenesis of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Immunohistological analysis for immunological response and mechanism of interstitial fibrosis in IgG4-related kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

IgG4-related kidney disease--A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Diagnosis of IgG4-related tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Proposal for diagnostic criteria for IgG4-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Diagnostic Approach to the Complexity of IgG4-Related Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Extrapancreatic findings of IgG4-related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Rituximab for IgG4-related disease: a prospective, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

Involvement of activation of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0279-4

The diagnostic utility of serum IgG4 concentrations in IgG4-related disease

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

IgG4-related kidney disease

1 reference

12 December 2020

Tubulointerstitial fibrosis in patients with IgG4-related kidney disease: pathological findings on repeat renal biopsy

1 reference

12 December 2020

IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease

1 reference

12 December 2020

1 reference

12 December 2020

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients

1 reference

12 December 2020

Treatment approaches to IgG4-related systemic disease

1 reference

12 December 2020

1 reference

12 December 2020

Membranous glomerulonephritis is a manifestation of IgG4-related disease

1 reference

12 December 2020

10.1007/S40620-016-0279-4

Identifiers

DOI

1 reference

PubMed ID

26972314

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

26972314